C. McCrae

发表

Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis.

D. Jayne, Arnaud Bourdin, Michael E. Wechsler, 2024, The New England journal of medicine.

Eosinophil Depletion with Benralizumab for Eosinophilic Esophagitis.

A. Bredenoord, I. Hirano, J. Caldwell, 2024, The New England journal of medicine.

Pharmacokinetics/pharmacodynamics of benralizumab in chronic rhinosinusitis with nasal polyps: Phase III, randomized, placebo-controlled OSTRO trial.

Joseph K. Han, C. Hopkins, Claus Bachert, 2024, British journal of clinical pharmacology.